12/20/2024 3:42 PM | Galera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2024 6:17 AM | Galera Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/15/2024 4:25 PM | Galera Therapeutics (Filer)
| Form NT 10-Q | |
10/18/2024 7:05 AM | Galera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/06/2024 6:38 AM | Galera Therapeutics (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
09/04/2024 6:01 AM | Galera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 6:00 AM | Galera Therapeutics (Filer)
| Form DEF 14A | |
|
08/23/2024 6:00 AM | Galera Therapeutics (Filer)
| Form PRE 14A | |
08/20/2024 3:45 PM | Galera Therapeutics (Issuer) Sorensen Mel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 11:52 AM | Galera Therapeutics (Subject) Sorensen Mel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024 6:30 AM | Galera Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024 6:05 AM | Galera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 6:10 AM | Galera Therapeutics (Subject)
| Form 425 | |
08/08/2024 6:00 AM | Galera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 6:02 AM | Galera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/03/2024 6:00 AM | Galera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2024 9:25 AM | Galera Therapeutics (Subject) Soffer Rochel (Filed by)
| Form SC 13G | |
05/16/2024 9:26 AM | Galera Therapeutics (Subject) Schneid Yair (Filed by)
| Form SC 13G/A | |
05/16/2024 9:26 AM | ALPHA PHARMA Investments LLC (Reporting) Galera Therapeutics (Issuer) Soffer Rochel (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/13/2024 6:30 AM | Galera Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024 6:05 AM | Galera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2024 3:07 PM | Galera Therapeutics (Filer)
| Form 8-A12B | |
05/01/2024 4:02 PM | Galera Therapeutics (Issuer) Schneid Yair (Reporting)
| Form 4/A | |
04/16/2024 3:39 PM | ALPHA PHARMA Investments LLC (Filed by) Galera Therapeutics (Subject)
| Form SC 13G | |
04/03/2024 7:08 AM | Altamont Pharmaceutical Holdings, LLC (Filed by) Galera Therapeutics (Subject)
| Form SC 13G/A | |
04/01/2024 8:36 PM | Altamont Pharmaceutical Holdings, LLC (Reporting) Galera Therapeutics (Issuer) Pearson Mark E. (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
03/28/2024 6:30 AM | Galera Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/28/2024 6:06 AM | Galera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2024 6:31 AM | Galera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 5:57 PM | Galera Therapeutics (Subject) Sofinnova Venture Partners IX, L.P. (Filed by)
| Form SC 13D/A | |
01/16/2024 5:11 PM | Galera Therapeutics (Issuer) Schneid Yair (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:35 AM | Galera Therapeutics (Subject) GSA CAPITAL PARTNERS LLP (Filed by)
| Form SC 13G | |